Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis

(2016) Marie-Jeanne Bertrand et al.   EXPERT OPINION ON EMERGING DRUGS

Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

(2016) Douglas S Jones et al.   Nature Chemical Biology

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours

(2015) S J Thomas et al.   BRITISH JOURNAL OF CANCER

Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis

(2015) M. Fallahi-Sichani et al.   Molecular Systems Biology

Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases

(2015) Daniella M. Schwartz et al.   Nature Reviews Rheumatology

Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease

(2014) Marie Fisk et al.   American Journal of Cardiovascular Drugs

Analysis of growth factor signaling in genetically diverse breast cancer lines

(2014) Mario Niepel et al.   BMC BIOLOGY

p38 MAPK: A Potential Target of Chronic Pain

(2014) X. Lin et al.   CURRENT MEDICINAL CHEMISTRY

The fibroblast as a therapeutic target in rheumatoid arthritis

(2013) Andrew Filer   CURRENT OPINION IN PHARMACOLOGY

New treatments for COPD

(2013) Anta Ngkelo et al.   CURRENT OPINION IN PHARMACOLOGY

The Emerging Role of p38 Mitogen-Activated Protein Kinase in Multiple Sclerosis and Its Models

(2013) D. N. Krementsov et al.   MOLECULAR AND CELLULAR BIOLOGY

Discovery of Potent and Selective Covalent Inhibitors of JNK

(2012) Tinghu Zhang et al.   CHEMISTRY & BIOLOGY

Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis

(2012) Sabrina Dadoun et al.   JOINT BONE SPINE

Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

(2012) Nunzio Bottini et al.   Nature Reviews Rheumatology

Sustained rheumatoid arthritis remission is uncommon in clinical practice

(2012) Femke HM Prince et al.   ARTHRITIS RESEARCH & THERAPY

Crosstalk and Signaling Switches in Mitogen-Activated Protein Kinase Cascades

(2012) Dirk Fey et al.   Frontiers in Physiology

Characterization of the cellular action of the MSK inhibitor SB-747651A

(2011) Shaista Naqvi et al.   BIOCHEMICAL JOURNAL

Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase

(2011) Shaun R. Selness et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

NF-κB in immunobiology

(2011) Matthew S Hayden et al.   CELL RESEARCH

Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

(2011) M. Cargnello et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Comprehensive analysis of kinase inhibitor selectivity

(2011) Mindy I Davis et al.   NATURE BIOTECHNOLOGY

The Pathogenesis of Rheumatoid Arthritis

(2011) Iain B. McInnes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture

(2010) Hans P. Kiener et al.   ARTHRITIS AND RHEUMATISM

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

(2010) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Cross-talk between the p38α and JNK MAPK Pathways Mediated by MAP Kinase Phosphatase-1 Determines Cellular Sensitivity to UV Radiation

(2010) Christopher J. Staples et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

TNF-α and neuropathic pain - a review

(2010) Lawrence Leung et al.   Journal of Neuroinflammation

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

Networks Inferred from Biochemical Data Reveal Profound Differences in Toll-like Receptor and Inflammatory Signaling between Normal and Transformed Hepatocytes

(2010) Leonidas G. Alexopoulos et al.   MOLECULAR & CELLULAR PROTEOMICS

A Multitude of Kinases—Which are the Best Targets in Treating Rheumatoid Arthritis?

(2010) Tamsin M. Lindstrom et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Rheumatoid arthritis progression mediated by activated synovial fibroblasts

(2010) Elena Neumann et al.   TRENDS IN MOLECULAR MEDICINE

Biologic Therapy for Rheumatoid Arthritis

(2009) Laura J. Gibbons et al.   BIODRUGS

CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activationversusproliferation

(2009) Cristina Casals-Casas et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis

(2009) Beatrix Bartok et al.   IMMUNOLOGICAL REVIEWS

Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders

(2009) David M. Goldstein et al.   JOURNAL OF MEDICINAL CHEMISTRY

Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages

(2009) Gabriela Molina et al.   Nature Chemical Biology

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

(2009) Stephanie Lefèvre et al.   NATURE MEDICINE

Targeting innate immunity protein kinase signalling in inflammation

(2009) Matthias Gaestel et al.   NATURE REVIEWS DRUG DISCOVERY

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

(2009) Peter C. Taylor et al.   Nature Reviews Rheumatology

Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-κB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis

(2009) Seong-Su Nah et al.   RHEUMATOLOGY INTERNATIONAL

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

(2008) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis

(2008) Erika H. Noss et al.   IMMUNOLOGICAL REVIEWS

Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties

(2007) Mary Mader et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival

(2007) Melissa R. Junttila et al.   FASEB JOURNAL